174 related articles for article (PubMed ID: 37770925)
1. SQLE Knockdown inhibits bladder cancer progression by regulating the PTEN/AKT/GSK3β signaling pathway through P53.
Zou F; Chen W; Song T; Xing J; Zhang Y; Chen K; Hu W; Li L; Ning J; Li C; Yu W; Cheng F
Cancer Cell Int; 2023 Sep; 23(1):221. PubMed ID: 37770925
[TBL] [Abstract][Full Text] [Related]
2. Reduction of Squalene Epoxidase by Cholesterol Accumulation Accelerates Colorectal Cancer Progression and Metastasis.
Jun SY; Brown AJ; Chua NK; Yoon JY; Lee JJ; Yang JO; Jang I; Jeon SJ; Choi TI; Kim CH; Kim NS
Gastroenterology; 2021 Mar; 160(4):1194-1207.e28. PubMed ID: 32946903
[TBL] [Abstract][Full Text] [Related]
3. Squalene epoxidase-induced cholesteryl ester accumulation promotes nasopharyngeal carcinoma development by activating PI3K/AKT signaling.
Li L; Zhang Q; Wang X; Li Y; Xie H; Chen X
Cancer Sci; 2020 Jul; 111(7):2275-2283. PubMed ID: 32314495
[TBL] [Abstract][Full Text] [Related]
4. Squalene Epoxidase Metabolic Dependency Is a Targetable Vulnerability in Castration-Resistant Prostate Cancer.
Shangguan X; Ma Z; Yu M; Ding J; Xue W; Qi J
Cancer Res; 2022 Sep; 82(17):3032-3044. PubMed ID: 35767703
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of squalene epoxidase linking with PI3K/AKT signaling pathway suppresses endometrial cancer.
Ma L; Huang W; Liang X; Bai G; Wang X; Jiang H; Xin Y; Hu L; Chen X; Liu C
Cancer Sci; 2023 Sep; 114(9):3595-3607. PubMed ID: 37438885
[TBL] [Abstract][Full Text] [Related]
6. Age-related cholesterol and colorectal cancer progression: Validating squalene epoxidase for high-risk cases.
Jun SY; Yoon HR; Yoon JY; Lee JJ; Kim JY; Kim JM; Kim NS
Aging Cell; 2024 Mar; ():e14152. PubMed ID: 38517197
[TBL] [Abstract][Full Text] [Related]
7. Squalene epoxidase facilitates cervical cancer progression by modulating tumor protein p53 signaling pathway.
Guo M; Qiao Y; Lu Y; Zhu L; Zheng L
J Obstet Gynaecol Res; 2023 May; 49(5):1383-1392. PubMed ID: 36843235
[TBL] [Abstract][Full Text] [Related]
8. SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src/PI3K/Akt signaling pathway.
Xu R; Song J; Ruze R; Chen Y; Yin X; Wang C; Zhao Y
Cell Death Dis; 2023 Aug; 14(8):497. PubMed ID: 37542052
[TBL] [Abstract][Full Text] [Related]
9. Squalene epoxidase promotes colorectal cancer cell proliferation through accumulating calcitriol and activating CYP24A1-mediated MAPK signaling.
He L; Li H; Pan C; Hua Y; Peng J; Zhou Z; Zhao Y; Lin M
Cancer Commun (Lond); 2021 Aug; 41(8):726-746. PubMed ID: 34268906
[TBL] [Abstract][Full Text] [Related]
10. Squalene epoxidase expression is associated with breast tumor progression and with a poor prognosis in breast cancer.
Kim NI; Park MH; Kweon SS; Cho N; Lee JS
Oncol Lett; 2021 Apr; 21(4):259. PubMed ID: 33664822
[TBL] [Abstract][Full Text] [Related]
11. Squalene epoxidase (SQLE) promotes the growth and migration of the hepatocellular carcinoma cells.
Sui Z; Zhou J; Cheng Z; Lu P
Tumour Biol; 2015 Aug; 36(8):6173-9. PubMed ID: 25787749
[TBL] [Abstract][Full Text] [Related]
12. Squalene epoxidase promotes the proliferation and metastasis of lung squamous cell carcinoma cells though extracellular signal-regulated kinase signaling.
Ge H; Zhao Y; Shi X; Tan Z; Chi X; He M; Jiang G; Ji L; Li H
Thorac Cancer; 2019 Mar; 10(3):428-436. PubMed ID: 30734525
[TBL] [Abstract][Full Text] [Related]
13. p53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth.
Sun H; Li L; Li W; Yang F; Zhang Z; Liu Z; Du W
EMBO Rep; 2021 Oct; 22(10):e52537. PubMed ID: 34459531
[TBL] [Abstract][Full Text] [Related]
14. Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis.
Li C; Wang Y; Liu D; Wong CC; Coker OO; Zhang X; Liu C; Zhou Y; Liu Y; Kang W; To KF; Sung JJ; Yu J
Gut; 2022 Nov; 71(11):2253-2265. PubMed ID: 35232776
[TBL] [Abstract][Full Text] [Related]
15. Squalene monooxygenase facilitates bladder cancer development in part by regulating PCNA.
Zhu C; Fang X; Liu X; Jiang C; Ren W; Huang W; Jiang Y; Wang D
Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119681. PubMed ID: 38280406
[TBL] [Abstract][Full Text] [Related]
16. Squalene epoxidase/SQLE is a candidate target for treatment of colorectal cancers with
Du Y; Rokavec M; Hermeking H
Int J Biol Sci; 2023; 19(13):4103-4122. PubMed ID: 37705742
[TBL] [Abstract][Full Text] [Related]
17. DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis.
Luo Y; He Z; Liu W; Zhou F; Liu T; Wang G
Oxid Med Cell Longev; 2022; 2022():3369858. PubMed ID: 35103094
[TBL] [Abstract][Full Text] [Related]
18. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
19. Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.
Liu D; Wong CC; Fu L; Chen H; Zhao L; Li C; Zhou Y; Zhang Y; Xu W; Yang Y; Wu B; Cheng G; Lai PB; Wong N; Sung JJY; Yu J
Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669855
[TBL] [Abstract][Full Text] [Related]
20. Squalene epoxidase promotes hepatocellular carcinoma development by activating STRAP transcription and TGF-β/SMAD signalling.
Zhang Z; Wu W; Jiao H; Chen Y; Ji X; Cao J; Yin F; Yin W
Br J Pharmacol; 2023 Jun; 180(12):1562-1581. PubMed ID: 36581319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]